Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial

Author(s):: Bone, H.G.; Dempster, D.W.; Eisman, J.A.; Greenspan, S.L.; McClung, M.R.; Nakamura, T.; Papapoulos, S.; Shih, W.J.; Rybak-Feiglin, A.; Santora, A.C.; Verbruggen, N.; Leung, A.T.; Lombardi, A.

Published: 2015
Publication type: Article / Letter to editor

Cathepsin KFractureOdanacatibOsteoporosisPostmenopausal

Date issued: 2015-02-28
Language: English
Is part of: Osteoporosis International (2015), Vol. 26, no. 2, p. 699-712
hdl: 1887/107872
doi: 10.1007/s00198-014-2944-6